APVO

0.40611.88%
JE

John E. Niederhuber

Lead Independent Director

Dr. John E. Niederhuber, M.D. is Scientific Advisory Board Member at OncoNano Medicine Inc. He served as the Chief Executive Officer of Inova Health Systems, Inc. He was Founder of the Inova Translational Medicine Institute and was its Chief Executive Officer until 2019. He served as Senior Advisor at Arsenal Capital Partners and focused on BioPharma and Life Sciences. He was founding President and Chief Executive Officer of the Genomics and Bioinformatics Research Institute, a joint venture between Inova and the University of Virginia. Dr. Niederhuber serves as an Adjunct Investigator at National Cancer Institute's Center for Cancer Research. Dr. Niederhuber serves in clinical position on the NIH Clinical Center Medical Staff. He served management and advisory roles and involved in research, through his laboratory on the National Institutes of Health (NIH) campus. Dr. Niederhuber served as Director of Comprehensive Cancer Center at the University of Wisconsin. Dr. Niederhuber served as NCI's Chief Operating Officer and Deputy Director for Translational and Clinical Sciences. He served as an NIH Academic Trainee in Surgery at the University of Michigan from 1969 to 1970. He has dedicated his four-decade career to the treatment and study of cancer. He served as an Executive Vice President of Inova Health Systems, Inc. since joining in August 2010. He served as Chief Executive Officer and Deputy Director for Translational and Clinical Sciences of the Inova Institute for Translational Research and Personalized Medicine. Dr. Niederhuber served as the Chairman of the National Cancer Advisory Board from 2002 to 2004. He served as Chairman of the Department of Surgery at Stanford University from 1991 to 1997. He serves as Independent Chairman at Aptevo Therapeutics Inc. since April 01, 2022 and also serves as its Independent Director since August 01, 2016 and served as its Lead Independent Director since August 01, 2016 and also served as its Vice Chairman until April 01, 2022. He has been a Director of Virginia Biotechnology Association since December 2015. He served as a Director of PierianDx, Inc. He is a Member of the Scientific Advisory Board of ProCertus BioPharm, Inc. He was a Managing Editor of Abeloff’s Clinical Oncology, 5th edition at Elsevier Inc. He served on the Advisory Board of WIRB - Copernicus Group Oncology. He was Senior Advisor to Cartesian Therapeutics. Dr. Niederhuber served as a Director of Emergent BioSolutions, Inc. since August 2010 until May 26, 2016. Dr. Niederhuber was Director of the University of Wisconsin Comprehensive Cancer Center and professor of surgery and oncology (member of the McArdle Laboratory) at the University of Wisconsin School of Medicine from 1997 to 2005. He served as a Director of Cellectar Biosciences, Inc. from April 2011 to November 8, 2013. He was Director of the National Institutes of Health from 2006 to 2010. From 2005 to 2010, he served as Director of the National Cancer Institute. In this position, his accomplishments include advancing drug and technology innovation and technology infrastructure, having cancer science to patients through community cancer centers and working to reduce the inequities of cancer care. He also served as Chief Operating Officer at National Cancer Institute. He was a Professor of surgery and oncology (Member of the McArdle Laboratory) at the University of Wisconsin School of Medicine and held professorships at the Johns Hopkins University School of Medicine from 1987 to 1991. He was a Member of the faculty of the University of Michigan from 1973 to 1987 and was its Professor of Microbiology/Immunology and Professor of Surgery in 1980. From 1986 to 1987, he was Visiting Professor in the Department of Molecular Biology and Genetics at The Johns Hopkins University School of Medicine in Baltimore, MD. He is Director Emeritus at National Cancer Institute of the National Institutes of Health. He served as a Member of Advisory Council of Sus Clinicals Inc until June 2024. Dr. Niederhuber is a Member of the Institute of Medicine of the National Academy of Science and has received numerous honors and awards. He was a Visiting Fellow in the Division of Immunology at The Karolinska Institute in Stockholm, Sweden from 1970 to 1971. Dr. Niederhuber earned a Bachelor of Science in Chemistry from Bethany College and his M.D. from The Ohio State University School of Medicine. He is a Member of the National Academy of Medicine.

Positions